BASS SID R
Follow13F filer, CIK 1242829, FORT WORTH, TX
BASS SID R reported $0 across 1 holding for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-05.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000897423-25-000012
Changes against Q3 2024 are not shown: its report omitted holdings under a confidential treatment request (1 position on file), so every position would read as new.
The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.
- Period
- 2024-12-31
- Reported value
- $0
- Holdings
- 1
- Top 10 weight
- New
- Sold out
Stakes and trades reported after 2024-12-31
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- AQST AQUESTIVE THERAPEUTICS INC: 13G 9,385,561 shares, 7.5% of the class, 13G filed 2026-10-07, 0000897423-26-000125Timeline
Accepted , ingested
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0000897423-25-000012, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| 00 | 0 | $0 | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios.The filing omitted confidential holdings, a later amendment may add them. |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000897423-25-000012 | base | 2025-02-05 | acceptance time not in the bulk data set |